Vancomycin Market
Vancomycin Market Analysis by Type (Daptomycin, Linezolid, Quinupristin, Ampicillin), by Application (Sepsis, Lung Infection, Skin Soft Tissue Infection, Colitis & Intestinal Inflammation), by Region 0- Global Forecast 2021 to 2027
Analysis of Vancomycin market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Vancomycin Market Outlook (2021 to 2027)
The global vancomycin market is projected to increase from a valuation of US$ 313.7 Mn in 2020 to US$ 465.1 Mn by the end of 2027. Demand for vancomycin to expand at a CAGR of 5.8% during the forecast period.
| Report Attributes | Details |
|---|---|
| Vancomycin Market Size (2020) | US$ 313.7 Mn |
| Projected Year Value (2027) | US$ 465.1 Mn |
| Global Market Growth Rate (2021 to 2027) | 5.8% CAGR |
| China Market Growth Rate (2021 to 2027) | 9.4% |
| Key Companies Profiled | Alvogen; MGB Biopharma Limited; Oragenics; Aphios Corporation; Microbiotix |
Demand for linezolid is set to increase at the highest CAGR over the forecast period with a broad spectrum of activity against many gram-positive bacteria.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Vancomycin from 2017 to 2020 Vs Market Outlook for 2021 to 2027
“Rising Prevalence of Infectious Diseases to Stimulate Industry Growth”
The global market for vancomycin was valued at US$ 313.7 Mn in 2020.
Vancomycin is a glycopeptide antibiotic that is used to treat certain infections caused by methicillin-resistant Staphylococcus aureus, such as skin infections, sepsis, endocarditis, bone & joint infections, and meningitis. Inflammatory medicines are usually administered as a first-line treatment, with doses adjusted according to the patient's blood concentration.
Blood levels can be examined to determine the correct dose. When taken through the parenteral route, it is also suggested as a treatment for severe clostridium difficile colitis. When taken by mouth, it is poorly absorbed. Adverse effects such as injection site pain and allergic reactions are prevalent. It's also probably safe to use when breastfeeding. It's a glycopeptide antibiotic that works by inhibiting cell walls from forming.
Vancomycin demand is predicted to grow due to rising prevalence of infectious diseases, increased awareness programs, and government financing for the research and development of new treatments. The market is predicted to expand at a 5.8% CAGR from 2021 to 2027.
Which Market Growth Trends are Driving Consumption of Vancomycin?
“Positive Mechanism of Vancomycin & Rising Investments in R&D Activities to Foster Market Expansion”
The bactericidal activity of vancomycin is mostly due to its reduction of cell-wall formation. It prevents N-acetylmuramic acid and N-acetylglucosamine peptide subunits from being incorporated into the peptidoglycan matrix, the most critical structural component of Gram-positive cell walls.
Vancomycin forms hydrogen bonds with D-alanyl-D-alanine moieties at the end of the peptide, preventing them from being integrated into the peptidoglycan matrix. It also has an impact on bacterial cell membrane permeability and RNA synthesis.
No cross-resistance occurs between vancomycin and other antibiotic medications. Vancomycin does not have any effect on gram-negative bacteria, mycobacteria, or even fungi in vitro.
The global vancomycin industry is growing as antibiotic consumption rises in low- and middle-income nations, with pharmaceutical companies investing heavily in research and development, besides the rising prevalence of infectious diseases.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Might Restrain Demand for Vancomycin to Some Extent?
“Rising Use of Generic Alternatives & Certain Side Effects Hampering Market Value”
Two typical adverse drug reactions associated with IV vancomycin are severe local pain and thrombophlebitis (which affect about 1% of patients). Clinical experiments conducted in the mid-1950s revealed that early impure versions of vancomycin tablets caused kidney damage (nephrotoxicity) and hearing loss (ototoxicity). Nephrotoxicity was discovered to be a rare adverse effect in later investigations using purer forms of vancomycin (0.1% to 1% of patients).
Certain limitations, such as rising use of generic alternatives, particularly as patents expire, and short lifecycle of medications, are expected to hinder vancomycin market growth.
Which Regional Vancomycin Market is Leading Revenue Generation?
“Rise in VRSA Infections to Boost Market Revenue in North America”
North America is expected to hold a significant share of the global vancomycin market because of rising vancomycin-resistant Staphylococcus aureus (VRSA) infections, increased R&D initiatives, and rising demand for new treatments.
The developed healthcare sector and increased consumer awareness about various treatments for infectious illnesses are driving market growth in North America.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Country-wise Insights
Why is the U.S. an Emerging Market for Vancomycin Suppliers?
“Rapid Deployment of Innovative Treatments Driving Market Expansion”
The U.S. vancomycin market was valued at US$ 84.5 Mn in 2020 and is anticipated to rise at the highest CAGR over the forecast period.
The United States is expected to provide lucrative revenue growth possibilities for vancomycin suppliers because of rising consumer healthcare spending and early acceptance of innovative and new treatments.
Existence of prominent manufacturers and advanced healthcare facilities are driving market growth in the U.S. The United States is projected to dominate the market owing to the growing usage of superior technical equipment and well-established healthcare infrastructure.
What is the Vancomycin Market Outlook for China?
“Government Initiatives for Infection Control to Fuel Market Growth”
The market in China is projected to reach a valuation of US$ 102.3 Mn by 2027, representing a 9.4% CAGR from 2021 to 2027.
China is expected to occupy a considerable share of the global vancomycin market due to rising population, greater healthcare awareness, and higher demand for early-phase identification.
Growing number of pharmaceutical manufacturers, government help for infection control, and widespread use of generic drugs are driving market expansion in the country.
Category-wise Insights
Which Vancomycin Type Accounts for Highest Revenue Generation?
“Growing Usage of Linezolid for Infection Prevention”
Linezolid is a drug that is used to treat infections such as pneumonia and skin diseases. Linezolid belongs to the oxazolidinones class of antibacterials. It works by preventing bacteria from growing.
The linezolid segment is projected to occupy a significant share of the global vancomycin market due to growing usage of linezolid and its capacity to treat a variety of gram-positive bacterial infections. Moreover, improved disease diagnostic techniques, as well as increased research on combination medicines, will drive market demand.
Which Application Will Emerge as Key Market Contributor?
“Increasing Consumption of Sepsis Drugs & Treatments Driving Market Demand”
According to the Centers for Disease Control and Prevention (CDC), there are roughly 1.7 million instances of sepsis each year. Furthermore, in the United States, this sort of illness kills nearly 270,000 people each year.
The body's severe response to an infection is known as sepsis. Sepsis occurs when an existing infection sets off a chain reaction throughout the body. Sepsis can quickly progress to tissue damage, organ failure, and death if not treated promptly.
Sepsis drugs and treatments are cost-effective and considered the first line of treatment, making the sepsis application segment the most profitable over the forecast period.
Competitive Landscape
Vancomycin is a competitive and moderately fragmented market. There are many players in the sector under scrutiny, including both, small and large pharmaceutical companies. Furthermore, a wave of early-stage biotech companies has entered the market in response to developing antibiotic resistance.
For instance :
- In February 2022, Magnolia Medical Technologies, Inc., the producer of Steripath®, which is the only FDA 510(k)-complaint device platform for the reduction of blood culture contamination for sepsis testing1, revealed US$ 46 million of growth equity financing led by RTW Investments, LP ("RTW"), and Sectoral Asset Management.
Key Segments Covered in Vancomycin Industry Research
-
By Type :
- Daptomycin
- Linezolid
- Quinupristin
- Ampicillin
- Chloramphenicol
- Others
-
By Application :
- Sepsis
- Lung Infection
- Skin Soft Tissue Infection
- Colitis & Intestinal Inflammation
- Other Infections
-
By Region :
- North America Vancomycin Market
- Europe Vancomycin Market
- Asia Pacific Vancomycin Market
- Latin America Vancomycin Market
- MEA Vancomycin Market
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2017 to 2020 and Forecast, 2021 to 2027
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2017 to 2020 and Forecast, 2021 to 2027
- 9. Global Market Analysis 2017 to 2020 and Forecast 2021 to 2027, by Type
- 9.1. Daptomycin
- 9.2. Linezolid
- 9.3. Quinupristin
- 9.4. Ampicillin
- 9.5. Chloramphenicol
- 9.6. Others
- 10. Global Market Analysis 2017 to 2020 and Forecast 2021 to 2027, by Application
- 10.1. Sepsis
- 10.2. Lung Infection
- 10.3. Skin Soft Tissue Infection
- 10.4. Colitis & Intestinal Inflammation
- 10.5. Other Infections
- 11. Global Market Analysis 2017 to 2020 and Forecast 2021 to 2027, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2017 to 2020 and Forecast 2021 to 2027
- 13. Latin America Market Analysis 2017 to 2020 and Forecast 2021 to 2027
- 14. Europe Market Analysis 2017 to 2020 and Forecast 2021 to 2027
- 15. South Asia Market Analysis 2017 to 2020 and Forecast 2021 to 2027
- 16. East Asia Market Analysis 2017 to 2020 and Forecast 2021 to 2027
- 17. Oceania Market Analysis 2017 to 2020 and Forecast 2021 to 2027
- 18. Middle East and Africa Market Analysis 2017 to 2020 and Forecast 2021 to 2027
- 19. Key and Emerging Countries Market Analysis 2017 to 2020 and Forecast 2021 to 2027
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. Alvogen
- 21.2. MGB Biopharma Limited
- 21.3. Oragenics
- 21.4. Aphios Corporation
- 21.5. Microbiotix
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Application
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2017 to 2020 and Forecast 2021 to 2027, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Application
Table 08: Latin America Market Value (US$ Mn) Analysis 2017 to 2020 and Forecast 2021 to 2027, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Application
Table 11: Europe Market Value (US$ Mn) Analysis 2017 to 2020 and Forecast 2021 to 2027, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Application
Table 14: South Asia Market Value (US$ Mn) Analysis 2017 to 2020 and Forecast 2021 to 2027, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Application
Table 17: East Asia Market Value (US$ Mn) Analysis 2017 to 2020 and Forecast 2021 to 2027, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Application
Table 20: Oceania Market Value (US$ Mn) Analysis 2017 to 2020 and Forecast 2021 to 2027, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Application
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2017 to 2020 and Forecast 2021 to 2027, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Application
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2017 to 2020
Figure 02: Global Market Volume Forecast (in 000' Units), 2021 to 2027
Figure 03: Pricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Pricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Market Value Analysis (US$ Mn), 2017 to 2020
Figure 06: Global Market Value Forecast (US$ Mn), 2021 to 2027
Figure 07: Global Market Absolute $ Opportunity, 2021 to 2027
Figure 08: Global Market Share Analysis (%), By Type, 2021 to 2027
Figure 09: Global Market Y-o-Y Analysis (%), By Type, 2021 to 2027
Figure 10: Global Market Attractiveness Analysis by Type, 2021 to 2027
Figure 11: Global Market Share Analysis (%), By Application, 2021 to 2027
Figure 12: Global Market Y-o-Y Analysis (%), By Application, 2021 to 2027
Figure 13: Global Market Attractiveness Analysis by Application, 2021 to 2027
Figure 14: Global Market Share Analysis (%), By Region, 2021 to 2027
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2021 to 2027
Figure 16: Global Market Attractiveness Analysis by Region, 2021 to 2027
Figure 17: North America Market Value Share, By Type, 2021 (E)
Figure 18: North America Market Value Share, By Application, 2021 (E)
Figure 19: North America Market Value Share, By Country, 2021 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2017 to 2020
Figure 21: North America Market Value Forecast (US$ Mn), 2021 to 2027
Figure 22: North America Market Attractiveness Analysis by Type, 2021 to 2027
Figure 23: North America Market Attractiveness Analysis by Application, 2021 to 2027
Figure 24: North America Market Attractiveness Analysis by Country, 2021 to 2027
Figure 25: Latin America Market Value Share, By Type, 2021 (E)
Figure 26: Latin America Market Value Share, By Application, 2021 (E)
Figure 27: Latin America Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2017 to 2020
Figure 29: Latin America Market Value Forecast (US$ Mn), 2021 to 2027
Figure 30: Latin America Market Attractiveness Analysis by Type, 2021 to 2027
Figure 31: Latin America Market Attractiveness Analysis by Application, 2021 to 2027
Figure 32: Latin America Market Attractiveness Analysis by Country, 2021 to 2027
Figure 33: Europe Market Value Share, By Type, 2021 (E)
Figure 34: Europe Market Value Share, By Application, 2021 (E)
Figure 35: Europe Market Value Share, By Country, 2021 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2017 to 2020
Figure 37: Europe Market Value Forecast (US$ Mn), 2021 to 2027
Figure 38: Europe Market Attractiveness Analysis by Type, 2021 to 2027
Figure 39: Europe Market Attractiveness Analysis by Application, 2021 to 2027
Figure 40: Europe Market Attractiveness Analysis by Country, 2021 to 2027
Figure 41: South Asia Market Value Share, By Type, 2021 (E)
Figure 42: South Asia Market Value Share, By Application, 2021 (E)
Figure 43: South Asia Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2017 to 2020
Figure 45: South Asia Market Value Forecast (US$ Mn), 2021 to 2027
Figure 46: South Asia Market Attractiveness Analysis by Type, 2021 to 2027
Figure 47: South Asia Market Attractiveness Analysis by Application, 2021 to 2027
Figure 48: South Asia Market Attractiveness Analysis by Country, 2021 to 2027
Figure 49: East Asia Market Value Share, By Type, 2021 (E)
Figure 50: East Asia Market Value Share, By Application, 2021 (E)
Figure 51: East Asia Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2017 to 2020
Figure 53: East Asia Market Value Forecast (US$ Mn), 2021 to 2027
Figure 54: East Asia Market Attractiveness Analysis by Type, 2021 to 2027
Figure 55: East Asia Market Attractiveness Analysis by Application, 2021 to 2027
Figure 56: East Asia Market Attractiveness Analysis by Country, 2021 to 2027
Figure 57: Oceania Market Value Share, By Type, 2021 (E)
Figure 58: Oceania Market Value Share, By Application, 2021 (E)
Figure 59: Oceania Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2017 to 2020
Figure 61: Oceania Market Value Forecast (US$ Mn), 2021 to 2027
Figure 62: Oceania Market Attractiveness Analysis by Type, 2021 to 2027
Figure 63: Oceania Market Attractiveness Analysis by Application, 2021 to 2027
Figure 64: Oceania Market Attractiveness Analysis by Country, 2021 to 2027
Figure 65: Middle East and Africa Market Value Share, By Type, 2021 (E)
Figure 66: Middle East and Africa Market Value Share, By Application, 2021 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2017 to 2020
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2021 to 2027
Figure 70: Middle East and Africa Market Attractiveness Analysis by Type, 2021 to 2027
Figure 71: Middle East and Africa Market Attractiveness Analysis by Application, 2021 to 2027
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2021 to 2027
Figure 73: U. S. Market Value Analysis (US$ Mn), 2021 & 2027
Figure 74: U. S. Market Value Share, By Type, 2021 (E)
Figure 75: U. S. Market Value Share, By Application, 2021 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2021 & 2027
Figure 77: Canada Market Value Share, By Type, 2021 (E)
Figure 78: Canada Market Value Share, By Application, 2021 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2021 & 2027
Figure 80: Mexico Market Value Share, By Type, 2021 (E)
Figure 81: Mexico Market Value Share, By Application, 2021 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2021 & 2027
Figure 83: Brazil Market Value Share, By Type, 2021 (E)
Figure 84: Brazil Market Value Share, By Application, 2021 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2021 & 2027
Figure 86: U. K. Market Value Share, By Type, 2021 (E)
Figure 87: U. K. Market Value Share, By Application, 2021 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2021 & 2027
Figure 89: Germany Market Value Share, By Type, 2021 (E)
Figure 90: Germany Market Value Share, By Application, 2021 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2021 & 2027
Figure 92: France Market Value Share, By Type, 2021 (E)
Figure 93: France Market Value Share, By Application, 2021 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2021 & 2027
Figure 95: Italy Market Value Share, By Type, 2021 (E)
Figure 96: Italy Market Value Share, By Application, 2021 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2021 & 2027
Figure 98: Spain Market Value Share, By Type, 2021 (E)
Figure 99: Spain Market Value Share, By Application, 2021 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2021 & 2027
Figure 101: Russia Market Value Share, By Type, 2021 (E)
Figure 102: Russia Market Value Share, By Application, 2021 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2021 & 2027
Figure 104: China Market Value Share, By Type, 2021 (E)
Figure 105: China Market Value Share, By Application, 2021 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2021 & 2027
Figure 107: Japan Market Value Share, By Type, 2021 (E)
Figure 108: Japan Market Value Share, By Application, 2021 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2021 & 2027
Figure 110: South Korea Market Value Share, By Type, 2021 (E)
Figure 111: South Korea Market Value Share, By Application, 2021 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2021 & 2027
Figure 113: India Market Value Share, By Type, 2021 (E)
Figure 114: India Market Value Share, By Application, 2021 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2021 & 2027
Figure 116: ASEAN Market Value Share, By Type, 2021 (E)
Figure 117: ASEAN Market Value Share, By Application, 2021 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2021 & 2027
Figure 119: Australia Market Value Share, By Type, 2021 (E)
Figure 120: Australia Market Value Share, By Application, 2021 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2021 & 2027
Figure 122: New Zealand Market Value Share, By Type, 2021 (E)
Figure 123: New Zealand Market Value Share, By Application, 2021 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2021 & 2027
Figure 125: GCC Countries Market Value Share, By Type, 2021 (E)
Figure 126: GCC Countries Market Value Share, By Application, 2021 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2021 & 2027
Figure 128: Turkey Market Value Share, By Type, 2021 (E)
Figure 129: Turkey Market Value Share, By Application, 2021 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2021 & 2027
Figure 131: South Africa Market Value Share, By Type, 2021 (E)
Figure 132: South Africa Market Value Share, By Application, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big was the vancomycin market in 2021?
In 2021, the global vancomycin market stood at a valuation of US$ 331.5 Mn.
What will the China vancomycin market be worth by 2027?
The China vancomycin market is anticipated to reach US$ 102.3 Mn by 2027.
What valuation will the vancomycin market reach by 2027?
Vancomycin sales are expected to reach US$ 465.1 Mn by 2027.
What is the predicted CAGR for the global vancomycin market over the forecast period?
From 2021 to 2027, global consumption of vancomycin is predicted to rise at a CAGR of 5.8%.
Who are the key suppliers of vancomycin?
Key suppliers of vancomycin are Alvogen, MGB Biopharma Limited, Oragenics, Aphios Corporation, and Microbiotix.
What are the key market statistics for vancomycin in Japan and Canada?
The market in Japan is expected to exhibit 3.1% CAGR, while Japan is set to experience a higher 4.6% CAGR, over the forecast period.
Vancomycin Market